Pri-Med Dallas | July 2025

Thursday−Friday, July 10–11|Dallas, TX

Pri-Med Dallas | Regional CME/CE Conference

Thursday, July 10 2025

12:25–1:10pm

Industry Theater

A Treatment Option for Appropriate Patients With Uncontrolled Moderate-to-Severe Atopic Dermatitis  

Industry Theater 1, Ballroom A4, Level 2

Description

Learn more about a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis (AD).

Faculty

Sponsored by

  • Sanofi and Regeneron Pharmaceuticals, Inc.